Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2019 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.
Capone S, Fusco FM, Milleri S, Borrè S, Carbonara S, Lo Caputo S, Leone S, Gori G, Maggi P, Cascio A, Lichtner M, Cauda R, Dal Zoppo S, Cossu MV, Gori A, Roda S, Confalonieri P, Bonora S, Missale G, Codeluppi M, Mezzaroma I, Capici S, Pontali E, Libanore M, Diani A, Lanini S, Battella S, Contino AM, Piano Mortari E, Genova F, Parente G, Dragonetti R, Colloca S, Visani L, Iannacone C, Carsetti R, Folgori A, Camerini R; COVITAR study group. Capone S, et al. Cell Rep Med. 2023 Jun 20;4(6):101084. doi: 10.1016/j.xcrm.2023.101084. Epub 2023 May 29. Cell Rep Med. 2023. PMID: 37315558 Free PMC article. Clinical Trial.
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.
Mangia A, Piazzolla V, Giannelli A, Visaggi E, Minerva N, Palmieri V, Carraturo I, Potenza D, Napoli N, Lauletta G, Tagarielli V, Santoro R, Piccigallo E, De Gioia S, Chimenti A, Cuccorese G, Metrangolo A, Mazzola M, Agostinacchio E, Mennea G, Sabbà C, Cela M, Copetti M, Losappio R. Mangia A, et al. Among authors: giannelli a. PLoS One. 2019 May 15;14(5):e0215783. doi: 10.1371/journal.pone.0215783. eCollection 2019. PLoS One. 2019. PMID: 31091254 Free PMC article.
[Cardiovascular Risk Assessment: preliminary results].
Palmieri L, Rielli R, Demattè L, Donfrancesco C, La Terza G, De Sanctis Caiola P, Dima F, Lo Noce C, Giannelli AM, Brignoli O, Cuffari A, De Rosa M, Addis A, Laurendi G, Giampaoli S. Palmieri L, et al. Among authors: giannelli am. G Ital Cardiol (Rome). 2010 Feb;11(2):154-61. G Ital Cardiol (Rome). 2010. PMID: 20408480 Italian.
Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.
Mangia A, Piazzolla V, Giannelli A, Visaggi E, Minerva N, Palmieri V, Carraturo I, Potenza D, Napoli N, Lauletta G, Tagarielli V, Santoro R, Piccigallo E, De Gioia S, Chimenti A, Cuccorese G, Metrangolo A, Mazzola M, Agostinacchio E, Mennea G, Sabbà C, Cela M, Copetti M, Losappio R. Mangia A, et al. Among authors: giannelli a. PLoS One. 2019 Sep 25;14(9):e0223287. doi: 10.1371/journal.pone.0223287. eCollection 2019. PLoS One. 2019. PMID: 31553772 Free PMC article.
[Cardiovascular Epidemiologic Observatory: temporal trends of cardiovascular risk factors].
Palmieri L, Lo Noce C, Vanuzzo D, Dima F, Donfrancesco C, Pilotto L, Ciccarelli P, Giannelli AM, Vannucchi S, Laurendi G, Giampaoli S; Gruppo di Ricerca dell'Osservatorio Epidemiologico Cardiovascolare. Palmieri L, et al. Among authors: giannelli am. G Ital Cardiol (Rome). 2010 May;11(5 Suppl 3):31S-36S. G Ital Cardiol (Rome). 2010. PMID: 20879476 Italian. No abstract available.